01/17/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/17/2020. This 22-page report summarizes an initiative to map available and pipeline diagnostics against antibacterial resistance (ABR), identify gaps in the availability of such diagnostics in low- and middle-income countries, and establish a research and development (R&D) priority list of diagnostics against ABR for the next three to five years. This mapping and list of gaps and priorities provided the basis for developing these consensus target product profiles (TPPs) for the highest-priority diagnostics on the R&D priority list. (PDF)
No hay comentarios:
Publicar un comentario